Fast Track Diagnostics SARL of Esch-sur-Alzette at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair

Fast Track Diagnostics SARL

29, rue Henri Koch, 4354 Esch-sur-Alzette
Luxembourg

Telephone +352 281 098-1
Fax +352 281 098-214
info@fast-trackdiagnostics.com

This company is co-exhibitor of
Luxemburg - Ministry of the Economy

Hall map

MEDICA 2017 hall map (Hall 3): stand B70

Fairground map

MEDICA 2017 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.04  Microbiology
  • 03.04.01  Bacteriology

Our products

Product category: Bacteriology

FTD Tropical fever core

Overview
Two tube multiplex for detection of dengue virus, chikungunya virus, West Nile virus, Plasmodium spp., Rickettsia spp., Leptospira spp., Salmonella spp. and internal control.

Principle
Multiplex Real-Time PCR for detection of pathogen genes by TaqMan® technology.

Targets
First tube multiplex PCR:

  • Dengue virus
  • Rickettsia spp.
  • Salmonella spp.
  • West Nile virus
Second tube multiplex PCR:

  • Plasmodium spp.
  • Chikungunya
  • Leptospira spp.
  • Internal control
Specimen
This test is for use with extracted nucleic acid from whole blood or urine samples of human origin.

Storage
-20°C

Shelf life
12 months

Equipment

More Less

Product category: Bacteriology

FTlyo Viral meningitis

Overview
Ready to use lyo master mix (8-well strips each) for detection of herpes simplex virus 1, herpes simplex virus 2, varicella zoster virus, mumps virus, enterovirus, human parechovirus including internal control.

Principle
Multiplex Real-Time PCR for detection of pathogen genes by TaqMan® technology.

Targets
First lyo master mix:

  • Herpes simplex virus 1
  • Herpes simplex virus 2
  • Mumps virus
  • Varicella zoster virus
Second lyo master mix:

  • Enterovirus
  • Human parechovirus
  • Internal control
Specimen
This test is for use with extracted nucleic acid from CSF and blood.

Storage
Liquid components: -20°C
Lyophilized components: 2-8°C

Shelf life
12 months

More Less

Product category: Bacteriology

FTD Epstein-Barr virus

Overview
One tube multiplex for detection AND quantification of Epstein-Barr virus including internal control.

Principle
Multiplex Real-Time PCR for detection of pathogen genes by TaqMan® technology.

Targets
One tube multiplex PCR:

  • Epstein-Barr virus
  • Internal control

Specimen
The quantitative validation of FTD Epstein-Barr virus was done with extracted nucleic acid from human EDTA or Citrate plasma with NucliSENS® easyMag® and ABI® 7500.

In clinical performance evaluation studies the test was also successfully qualitatively used with human EDTA blood, plasma and serum.

In case human EDTA blood or serum are intended to use for quantitative analysis, the procedure has to be validated by the user.

Storage
-20° C

Shelf life
12 months

More Less

Product category: Bacteriology

FTD Eye

Overview
Two tube multiplex for detection of herpes simplex virus 1, 2, varicella-zoster virus, adenovirus, Chlamydia trachomatis and internal control.

Principle
Multiplex Real-Time PCR for detection of pathogen genes by TaqMan® technology.

Targets
First tube multiplex PCR:

  • Herpes simplex virus 1
  • Herpes simplex virus 2
  • Varicella-Zoster virus
  • Internal control
Second tube multiplex PCR:

  • Chlamydia trachomatis
  • Adenovirus (AV)
  • Internal control

Specimen

This test is for use with extracted nucleic acid from eye swabs of human origin.

Storage
-20°C

Shelf life
12 months

More Less

Product category: Bacteriology

FTD Hepatitis B DNA

Overview
One tube multiplex for detection AND quantification of hepatitis B virus and internal control.

Principle
Multiplex Real-Time PCR for detection of pathogen genes by TaqMan® technology.

Fast-track diagnostics has decided to follow decision 2002/364/EC on common technical specifications for in vitro diagnostic medical devices: quantification standards have to be provided that allow the quantification of pathogens in International Units per millilitre (IU/ml) if available. The  standards for absolute quantification that are included in FTD kits are correlated with World Health Organisation standards. These standards are calibrated following extensive international studies and play an important role for the traceability and comparability of results between laboratories. Although FTD understands that certain customers, in particular clinicians, still prefer copies per ml, there are no internationally agreed standard in copies per ml and no internationally agreed formulae to convert IU to copies. Nevertheless, if you feel you still wish to use copies per ml, we will be happy to confirm your conversion calculations (based on your experimental data) for FTD kits.

Targets
One tube multiplex PCR:

  • Hepatitis B DNA
  • Internal control
Specimen
The quantitative validation of FTD Hepatitis B DNA was done with extracted nucleic acid from human EDTA or Citrate plasma with NucliSENS® easyMag® and ABI® 7500.

In clinical performance evaluation studies the test was also successfully qualitatively used with human EDTA plasma and serum.

In case human EDTA serum is intended to use for quantitative analysis, the procedure has to be validated by the user. Be aware that in serum samples the sensitivity of the test can be reduced.

Storage
-20°C

Shelf life
12 months

More Less

About us

Company details

Our Philosophy
Since its formation in 2007 Fast-track diagnostics has become established as one of the leading global suppliers of real-time PCR multiplex testing for infectious disease detection based on the syndromic approach.

We believe that providing a comprehensive diagnostic approach to a clinical syndrome is the most effective way to aid clinical management and we are dedicated to providing clinicians with the means to make faster, better informed decisions - giving them the true positives and true negatives needed to minimise uncertainty and lead to better patient outcomes.

Our mission has stayed consistent and we remain focused on developing assays which offer an unrivalled range of benefits to clinicians, laboratories and patients in terms of: 

  • Clinical relevance
  • Reliability
  • Choice
  • Ease of use
  • Compatibility with existing platforms
  • Time and cost efficiency

More Less